Clinical trial
Retrospective & Prospective Observational Study of Patients With Immune…
NCT00454857 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00454857 |
|---|---|
| Title | Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) |
| Official title | A Prospective Observational Descriptive Study and Retrospective Chart Review of Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Idiopathic Thrombocytopenic Purpura, Thrombocytopenia, Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP), Thrombocytopenic Purpura |
| Intervention type | Other |
| Interventions | Retrospective Chart Review, Patient-reported Outcome Questionnaires, Physician Survey |
| Enrollment | 326 |
| Start date | May 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Apr 2, 2007 |
| Last update posted | Nov 26, 2013 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: